Tenax Therapeutics (TENX) Preferred Shares Issued (2012 - 2013)
Tenax Therapeutics recorded quarterly Preferred Shares Issued of -$24995.0 in Q4 2013, down 100.51% quarter-over-quarter from $4.9 million in Q3 2013.
Tenax Therapeutics' Preferred Shares Issued history runs 2 years deep, the most recent figure standing at -$24995.0 for Q4 2013.
- In Q4 2013, Preferred Shares Issued changed N/A year-over-year to -$24995.0; the TTM figure through Jan 2014 stood at $6.7 million (up 169.85% YoY), while the FY2018 annual figure was $8.9 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$24995.0 for Q4 2013 at Tenax Therapeutics, down from $4.9 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $4.9 million in Q3 2013 to a low of -$24995.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2013 | -24,995.00 |
| Oct 31, 2013 | -24,995.00 |
| Jul 31, 2013 | 4.92 Mn |
| Jul 31, 2013 | 4.92 Mn |
| Apr 30, 2013 | 1.85 Mn |
| Apr 30, 2013 | 1.85 Mn |
| Jul 31, 2012 | 2.50 Mn |
| Jul 31, 2012 | 2.50 Mn |